SREBP-1c transcription factor and lipid homeostasis: clinical perspective
about
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patientsSelenium and diabetes--evidence from animal studiesLipid biology of breast cancerBeneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on ObesityRegulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1chnRNP A1 mediates the activation of the IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stressRole of FAT/CD36 in fatty acid sensing, energy, and glucose homeostasis regulation in DIO and DR ratsHepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid compositionIdentification of novel genes and pathways regulating SREBP transcriptional activityAnalysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditureMetabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patientsEffect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE-/- Mice Fed with a High-Fat Diet.mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesityEffects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.Experimental models of non-alcoholic fatty liver disease in rats.Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis.Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects.Maturation and activity of sterol regulatory element binding protein 1 is inhibited by acyl-CoA binding domain containing 3.Administration of a decoction of sucrose- and polysaccharide-rich radix astragali (huang qi) ameliorated insulin resistance and Fatty liver but affected Beta-cell function in type 2 diabetic rats.Age-related inflammation and insulin resistance: a review of their intricate interdependencyOmega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity.Intersection of the unfolded protein response and hepatic lipid metabolismPathophysiology of diabetic dyslipidaemia: where are we?mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).Early Life Exposure to Fructose Alters Maternal, Fetal and Neonatal Hepatic Gene Expression and Leads to Sex-Dependent Changes in Lipid Metabolism in Rat OffspringRGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogsAdvanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor κB (NF-κB).Moderate physical activity from childhood contributes to metabolic health and reduces hepatic fat accumulation in adult ratsRegulation of SREBP-Mediated Gene Expression.Mediating lipid biosynthesis: implications for cardiovascular diseaseNonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorderObesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms.
P2860
Q24630367-2D2B925C-C2E8-4236-8B1D-32FBB0B4B7F0Q26821855-34958690-7377-40B8-9214-1C7394948020Q27013858-8707A095-0841-437A-A09B-C2844BE46053Q28067256-722B1641-9961-4D0B-A8C1-2BC0116C2CFCQ28268591-C366EEF4-24B0-4AE8-ABB5-B1F1D8D06B99Q28297047-1563A3BD-FE37-49D9-B04D-B119030DFE7DQ28573820-F647393F-BEDB-4FD6-B22F-B919E162CA3CQ28577250-842AC84F-7B2B-4313-B954-7CEF50EE52F2Q33388523-E4CDFDF2-6CA4-473E-A111-2E65D3B55A38Q33432792-672062CE-F6C3-495C-82B9-AF469127197FQ33513320-FBB77CF1-75D6-4CA8-BDD1-375C7282CC71Q33594722-5758933A-4149-49F8-8BEF-1E4D1468AB1DQ33604032-A05B59D4-875E-4639-8777-AF6CB18EE23FQ33734395-9AD8BF6F-2F8E-45C3-931D-C3FF2CE6F751Q33789340-424B544A-8B43-48C9-ACAF-12793B1FF842Q33810241-8E2B72CE-4833-46CE-B8CD-A14BD9C58E5EQ33886936-61F884AC-F026-44C5-BBF7-98F97BA60B7DQ33997122-184868C4-090B-4171-91DE-9ACAC1B17457Q34037052-DEA7ED92-05B1-40B5-958E-30A9A0A31E02Q34171384-426EF469-D8AF-4725-A26B-13F44EE9CB08Q34292374-C63F2069-63D0-4024-A859-DF9B7D24EA0AQ34482862-A6C2DBCD-6920-473B-B8F5-37E1C8641ACAQ34512794-E30BB65C-3F81-48FA-A12A-E81097FE5536Q34580477-38751F93-EDA6-4B54-9A93-F2407081830DQ34760318-E3132528-9165-409D-BC42-A1B297FA22BAQ34929006-56F2DDF3-8C60-4D3D-9FD9-277090527362Q34985745-3028A8BD-2E25-455F-B836-7494FFDB488BQ35350326-7C6AE2BE-CA9F-4C1A-BF64-7A9C2770BA07Q35652651-789D6355-4F5C-4C8A-B5F0-70DECE9666CAQ35839881-05335705-DCEE-4969-9EE9-6055FD91D406Q35953156-22087C42-023C-4B7C-8613-6F2DCD99152DQ35993655-BE7F9600-D9D6-4C31-8C8A-E97E823B25A5Q36466224-80CEA77B-CD80-4AA8-8DD0-31C6FEF4ECE3Q36690629-76A872FD-87CD-42B9-A974-0C5940AE3EA1Q36886903-1CD1209B-B9D2-401B-9793-2BD84EA0FE7AQ37097833-C0434054-1694-46BC-AE2D-2422F288A2B3Q37149405-A19D1F80-3216-44F2-98DF-9350A07481FFQ37177378-03BC0267-4CB6-4672-A0A3-739E3F0E82AFQ37197043-2DC6907A-DB8F-4E3D-875D-D6637EEEA3C2Q37200269-EBF4C5FE-3EFA-4A45-8A7B-845275ECB9E5
P2860
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@ast
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@en
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@nl
type
label
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@ast
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@en
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@nl
prefLabel
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@ast
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@en
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@nl
P3181
P356
P1433
P1476
SREBP-1c transcription factor and lipid homeostasis: clinical perspective
@en
P2093
P3181
P356
10.1159/000100426
P407
P577
2007-03-05T00:00:00Z